Clinical Trial Update: A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a Phase 1/Phase 2 study of SHR-A1811 in combination with Pyrotinib or SHR-1316 in adults with advanced non-small cell lung cancer; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)
• SHR-1316
• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING